115 related articles for article (PubMed ID: 10372724)
1. Effects of gonadal suppression on the regulation of parathyroid hormone and 1,25-dihydroxyvitamin D secretion in women.
Finkelstein JS; Schoenfeld DA
J Clin Endocrinol Metab; 1999 Jun; 84(6):2151-6. PubMed ID: 10372724
[TBL] [Abstract][Full Text] [Related]
2. Effects of gonadal steroid suppression on skeletal sensitivity to parathyroid hormone in men.
Leder BZ; Smith MR; Fallon MA; Lee ML; Finkelstein JS
J Clin Endocrinol Metab; 2001 Feb; 86(2):511-6. PubMed ID: 11158001
[TBL] [Abstract][Full Text] [Related]
3. Increases in bone mineral density after discontinuation of daily human parathyroid hormone and gonadotropin-releasing hormone analog administration in women with endometriosis.
Finkelstein JS; Arnold AL
J Clin Endocrinol Metab; 1999 Apr; 84(4):1214-9. PubMed ID: 10199756
[TBL] [Abstract][Full Text] [Related]
4. Prevention of estrogen deficiency-related bone loss with human parathyroid hormone-(1-34): a randomized controlled trial.
Finkelstein JS; Klibanski A; Arnold AL; Toth TL; Hornstein MD; Neer RM
JAMA; 1998 Sep 23-30; 280(12):1067-73. PubMed ID: 9757854
[TBL] [Abstract][Full Text] [Related]
5. Effects of selective testosterone and estradiol withdrawal on skeletal sensitivity to parathyroid hormone in men.
Lee H; Finkelstein JS; Miller M; Comeaux SJ; Cohen RI; Leder BZ
J Clin Endocrinol Metab; 2006 Mar; 91(3):1069-75. PubMed ID: 16352679
[TBL] [Abstract][Full Text] [Related]
6. Response of the parathyroid gland to infusion of human parathyroid hormone-(1-34) [PTH-(1-34)]: demonstration of suppression of endogenous secretion using immunoradiometric intact PTH-(1-84) assay.
Cosman F; Shen V; Herrington B; Lindsay R
J Clin Endocrinol Metab; 1991 Dec; 73(6):1345-51. PubMed ID: 1955517
[TBL] [Abstract][Full Text] [Related]
7. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
8. Dose-dependent inhibition of pituitary-ovarian function during administration of a gonadotropin-releasing hormone agonistic analog (nafarelin).
Monroe SE; Blumenfeld Z; Andreyko JL; Schriock E; Henzl MR; Jaffe RB
J Clin Endocrinol Metab; 1986 Dec; 63(6):1334-41. PubMed ID: 2946710
[TBL] [Abstract][Full Text] [Related]
9. Calcium-regulating hormones during the menstrual cycle.
Pitkin RM; Reynolds WA; Williams GA; Hargis GK
J Clin Endocrinol Metab; 1978 Sep; 47(3):626-32. PubMed ID: 263315
[TBL] [Abstract][Full Text] [Related]
10. Effects of growth hormone administration on bone mineral metabolism, PTH sensitivity and PTH secretory rhythm in postmenopausal women with established osteoporosis.
Joseph F; Ahmad AM; Ul-Haq M; Durham BH; Whittingham P; Fraser WD; Vora JP
J Bone Miner Res; 2008 May; 23(5):721-9. PubMed ID: 18052753
[TBL] [Abstract][Full Text] [Related]
11. Regulation of calciotropic hormones in vivo in the New Zealand white rabbit.
Warren HB; Lausen NC; Segre GV; el-Hajj G; Brown EM
Endocrinology; 1989 Nov; 125(5):2683-90. PubMed ID: 2507295
[TBL] [Abstract][Full Text] [Related]
12. Parathyroid hormone for the prevention of bone loss induced by estrogen deficiency.
Finkelstein JS; Klibanski A; Schaefer EH; Hornstein MD; Schiff I; Neer RM
N Engl J Med; 1994 Dec; 331(24):1618-23. PubMed ID: 7969342
[TBL] [Abstract][Full Text] [Related]
13. Effects of growth hormone replacement on parathyroid hormone sensitivity and bone mineral metabolism.
Ahmad AM; Thomas J; Clewes A; Hopkins MT; Guzder R; Ibrahim H; Durham BH; Vora JP; Fraser WD
J Clin Endocrinol Metab; 2003 Jun; 88(6):2860-8. PubMed ID: 12788900
[TBL] [Abstract][Full Text] [Related]
14. The rapid ovarian secretory response to pituitary stimulation by the gonadotropin-releasing hormone agonist nafarelin in sexual precocity.
Rosenfield RL; Garibaldi LR; Moll GW; Watson AC; Burstein S
J Clin Endocrinol Metab; 1986 Dec; 63(6):1386-9. PubMed ID: 2946712
[TBL] [Abstract][Full Text] [Related]
15. Effect of experimental human magnesium depletion on parathyroid hormone secretion and 1,25-dihydroxyvitamin D metabolism.
Fatemi S; Ryzen E; Flores J; Endres DB; Rude RK
J Clin Endocrinol Metab; 1991 Nov; 73(5):1067-72. PubMed ID: 1939521
[TBL] [Abstract][Full Text] [Related]
16. Abnormalities of parathyroid hormone secretion in elderly women that are reversible by short term therapy with 1,25-dihydroxyvitamin D3.
Ledger GA; Burritt MF; Kao PC; O'Fallon WM; Riggs BL; Khosla S
J Clin Endocrinol Metab; 1994 Jul; 79(1):211-6. PubMed ID: 8027229
[TBL] [Abstract][Full Text] [Related]
17. Changes in vitamin D metabolism during natural and medical menopause.
Hartwell D; Riis BJ; Christiansen C
J Clin Endocrinol Metab; 1990 Jul; 71(1):127-32. PubMed ID: 2142491
[TBL] [Abstract][Full Text] [Related]
18. Vitamin D metabolites do not alter parathyroid hormone secretion acutely.
Magliola L; Anast CS; Forte LR
Bone Miner; 1986 Dec; 1(6):495-505. PubMed ID: 3509783
[TBL] [Abstract][Full Text] [Related]
19. Effect of parathyroid hormone (hPTH[1-34]) infusion on serum 1,25-dihydroxyvitamin D and parathyroid hormone in normal women.
Kinyamu HK; Gallagher JC; Petranick KM; Ryschon KL
J Bone Miner Res; 1996 Oct; 11(10):1400-5. PubMed ID: 8889838
[TBL] [Abstract][Full Text] [Related]
20. Effects of transdermal estrogen replacement on parathyroid hormone secretion.
Prince RL; Schiff I; Neer RM
J Clin Endocrinol Metab; 1990 Nov; 71(5):1284-7. PubMed ID: 2229285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
